Literature DB >> 21182081

Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication.

Kazutaka Honda1, Nan Zheng, Hayato Murakoshi, Masao Hashimoto, Keiko Sakai, Mohamed Ali Borghan, Takayuki Chikata, Madoka Koyanagi, Yoshiko Tamura, Hiroyuki Gatanaga, Shinichi Oka, Masafumi Takiguchi.   

Abstract

HIV-1 mutants escaping from HLA-A- or HLA-B-restricted CTL have been well studied, but those from HLA-C-restricted CTL have not. Therefore we investigated the ability of HLA-C-restricted CTL to select HIV-1 escape mutants. In the present study, we identified two novel HLA-Cw(*) 1202-restricted Pol-specific CTL epitopes (Pol328-9 and Pol463-10). CTL specific for these epitopes were detected in 25-40% of chronically HIV-1-infected HLA-Cw(*) 1202(+) individuals and had strong abilities to kill HIV-1-infected cells and to suppress HIV-1 replication in vitro, suggesting that these CTL may have the ability to effectively control HIV-1 in some HLA-Cw(*) 1202(+) individuals. Sequence analysis of these epitopes showed that a V-to-A substitution at the 9th position (V9A) of Pol 463-10 was significantly associated with the HLA-Cw(*) 1202 allele and that the V9A mutant was slowly selected in the HLA-Cw(*) 1202(+) individuals. Pol 463-10-specific CTL failed both to kill the V9A virus-infected cells and to suppress replication of the V9A mutant. These results indicate that the V9A mutation was selected as an escape mutant by the Pol463-10-specific CTL. The present study strongly suggests that some HLA-C-restricted CTL have a strong ability to suppress HIV-1 replication so that they can select HIV escape mutants as in the case of HLA-A-restricted or HLA-B-restricted CTL.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182081     DOI: 10.1002/eji.201040841

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.

Authors:  Tomohiro Akahoshi; Takayuki Chikata; Yoshiko Tamura; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Authors:  Hayato Murakoshi; Tomohiro Akahoshi; Madoka Koyanagi; Takayuki Chikata; Takuya Naruto; Rie Maruyama; Yoshiko Tamura; Naoki Ishizuka; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  Different Effects of Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Cytotoxic T Lymphocyte Recognition between HIV-1 Subtype B and Subtype A/E Infections.

Authors:  Nozomi Kuse; Mohammad Arif Rahman; Hayato Murakoshi; Giang Van Tran; Takayuki Chikata; Madoka Koyanagi; Kinh Van Nguyen; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

4.  High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism.

Authors:  Marie-Eve Blais; Yonghong Zhang; Tim Rostron; Harry Griffin; Stephen Taylor; Keyi Xu; Huiping Yan; Hao Wu; Ian James; Mina John; Tao Dong; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

5.  HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C12:02/C14:03.

Authors:  Zhansong Lin; Kimiko Kuroki; Nozomi Kuse; Xiaoming Sun; Tomohiro Akahoshi; Ying Qi; Takayuki Chikata; Takuya Naruto; Madoka Koyanagi; Hayato Murakoshi; Hiroyuki Gatanaga; Shinichi Oka; Mary Carrington; Katsumi Maenaka; Masafumi Takiguchi
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

6.  Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.

Authors:  Hayato Murakoshi; Madoka Koyanagi; Takayuki Chikata; Mohammad Arif Rahman; Nozomi Kuse; Keiko Sakai; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 7.  The emerging role of HLA-C in HIV-1 infection.

Authors:  Deanna A Kulpa; Kathleen L Collins
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

Review 8.  Co-evolution of MHC class I and variable NK cell receptors in placental mammals.

Authors:  Lisbeth A Guethlein; Paul J Norman; Hugo G Hilton; Peter Parham
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

9.  HIV-1 Vpu Mediates HLA-C Downregulation.

Authors:  Richard Apps; Gregory Q Del Prete; Pramita Chatterjee; Abigail Lara; Zabrina L Brumme; Mark A Brockman; Stuart Neil; Suzanne Pickering; Douglas K Schneider; Alicja Piechocka-Trocha; Bruce D Walker; Rasmi Thomas; George M Shaw; Beatrice H Hahn; Brandon F Keele; Jeffrey D Lifson; Mary Carrington
Journal:  Cell Host Microbe       Date:  2016-05-11       Impact factor: 21.023

Review 10.  HLA-C and HIV-1: friends or foes?

Authors:  Donato Zipeto; Alberto Beretta
Journal:  Retrovirology       Date:  2012-05-09       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.